Oppenheimer & Co’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,916
Closed -$109K 1558
2024
Q2
$109K Buy
14,916
+3,664
+33% +$32K ﹤0.01% 1381
2024
Q1
$113K Sell
11,252
-2,614
-19% -$22.9K ﹤0.01% 1384
2023
Q4
$97.2K Sell
13,866
-551
-4% -$3.66K ﹤0.01% 1335
2023
Q3
$114K Sell
14,417
-120,924
-89% -$763K ﹤0.01% 1313
2023
Q2
$750K Sell
135,341
-7,596
-5% -$41.7K 0.02% 821
2023
Q1
$813K Sell
142,937
-17,224
-11% -$114K 0.02% 763
2022
Q4
$1.12M Buy
160,161
+101,403
+173% +$1.04M 0.03% 634
2022
Q3
$524K Buy
58,758
+45,387
+339% +$524K 0.01% 878
2022
Q2
$138K Buy
13,371
+650
+5% +$9.65K ﹤0.01% 1316
2022
Q1
$265K Buy
+12,721
New +$278K ﹤0.01% 1250

Other funds holding MSOS

Oppenheimer & Co's MSOS Position: Q3 2024 in Review

Oppenheimer & Co sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2024, closing a stake of 14,916 shares — an estimated $109K sold.

Oppenheimer & Co first reported a position in MSOS in Q1 2022 and held it in 10 quarters. The position peaked at $1.12M in Q4 2022. 171 funds tracked by Wall St. Rank hold MSOS as of Q3 2024.

  • Oppenheimer & Co reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 14,916 AdvisorShares Pure US Cannabis ETF shares in Q3 2024, an estimated $109K.
  • Oppenheimer & Co first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and held it in 10 quarters.
  • Oppenheimer & Co's AdvisorShares Pure US Cannabis ETF position peaked at $1.12M in Q4 2022.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2024.

Based on Oppenheimer & Co's 13F filing for Q3 2024, filed 5 Nov 2024.